EUVIMEDEUVIMED entdecken
Crossref

Distribution of rapid HCV antibody self‐test kits via needle/syringe dispensing machines: Implementation and evaluation of the Vend‐C pilot study in Melbourne, Australia

Daniel O'Keefe iD, David Jacka, Caitlin Douglass, Jack Gunn, Mark Stoove, Sione Crawford, Mellissa Bryant, Peter Higgs, Paul Dietze, Margaret Hellard iD

Journal of Viral Hepatitis · 2024

DOI: 10.1111/jvh.13909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2024. Verfasst von Daniel O'Keefe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Burnet Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Substance Abuse, Intravenous, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Burnet Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent guidance from the World Health Organization strongly recommended hepatitis C virus (HCV) self‐testing. We implemented the Vend‐C pilot study to explore the effectiveness and feasibility of distributing rapid HCV antibody self‐test kits to people who inject drugs via needle/syringe dispensing machines (SDMs). Over a 51‐day study period between August and September 2022, we distributed HCV antibody self‐test kits via two SDMs. During the study period, 63 self‐test kits were dispensed, averaging 1.2 self‐test kits per day. Our access methods for evaluation questionnaires failed to attract participants ( n = 4). We implemented the Vend‐C pilot study in direct response to recent WHO recommendations. While self‐test kits were effectively distributed from the two SDMs, our evaluation methodology failed. Consequently, we cannot determine the success of linkage to care. Even so, with HCV treatment numbers dropping in Australia, innovative engagement solutions are needed, and considering the number of self‐test kits provided in our pilot, the model could have an important future place in HCV elimination efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Abuse, IntravenousHepatitis CHumansNeedle-Exchange ProgramsPilot ProjectsSyringesSelf-TestingAustraliaHepacivirusAntiviral Agents

Stichwörter der Autor:innen

harm reductionhepatitis C viruspeople who inject drugsresearch methodologyself-testing

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Burnet Institute, Melbourne, Victoria, Australia.
  • Monash Health, Dandenong, Victoria, Australia.
  • Harm Reduction Victoria, Brunswick, Victoria, Australia.

ORCID-Profile: Daniel O'Keefe, Margaret Hellard

Förderung

  • Burnet Institute

Zitieren

APA

O'Keefe, D., Jacka, D., Douglass, C., Gunn, J., Stoove, M., Crawford, S., Bryant, M., Higgs, P., Dietze, P., & Hellard, M. (2024). Distribution of rapid HCV antibody self‐test kits via needle/syringe dispensing machines: Implementation and evaluation of the Vend‐C pilot study in Melbourne, Australia. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13909

Vancouver

O'Keefe D, Jacka D, Douglass C, Gunn J, Stoove M, Crawford S, et al. Distribution of rapid HCV antibody self‐test kits via needle/syringe dispensing machines: Implementation and evaluation of the Vend‐C pilot study in Melbourne, Australia. Journal of Viral Hepatitis. 2024. doi:10.1111/jvh.13909

BibTeX
@article{OKeefe2024,
  author = {O'Keefe, Daniel and Jacka, David and Douglass, Caitlin and Gunn, Jack and Stoove, Mark and Crawford, Sione and Bryant, Mellissa and Higgs, Peter and Dietze, Paul and Hellard, Margaret},
  title = {Distribution of rapid HCV antibody self‐test kits via needle/syringe dispensing machines: Implementation and evaluation of the Vend‐C pilot study in Melbourne, Australia},
  journal = {Journal of Viral Hepatitis},
  year = {2024},
  doi = {10.1111/jvh.13909}
}
Kostenlos starten →